Ascendant Dx
Commercialize disruptive diagnostic technologies to aid in diagnosis and treatment of diseases of women and children.
Launch date
Employees
Market cap
-
Enterprise valuation
€7—11m (Dealroom.co estimates May 2014.)
Springdale Arkansas (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$2.0m | Seed | ||
| Total Funding | €1.8m | ||
Recent News about Ascendant Dx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.